IMP321
Showing 1 - 25 of 38
Metastatic Breast Cancer Trial (Eftilagimod Alpha, Paclitaxel)
Not yet recruiting
- Metastatic Breast Cancer
- Eftilagimod Alpha
- Paclitaxel
- (no location specified)
Aug 2, 2022
Solid Tumors, Peritoneal Carcinomatosis Trial in Frankfurt (IMP321, Avelumab)
Recruiting
- Solid Tumors
- Peritoneal Carcinomatosis
- IMP321
- Avelumab
-
Frankfurt, GermanyKrankenhaus Nordwest
Jul 12, 2021
Breast Carcinoma Trial in Houston (biological, drug, other)
Not yet recruiting
- Breast Carcinoma
- eftilagimod alpha
- +2 more
-
Houston, TexasOncology Consultants
Feb 17, 2023
Adenocarcinoma Breast Stage IV Trial in Worldwide (IMP321 (eftilagimod alpha), Placebo, Paclitaxel)
Completed
- Adenocarcinoma Breast Stage IV
- IMP321 (eftilagimod alpha)
- +2 more
-
Brugge, Belgium
- +28 more
Oct 4, 2021
Melanoma Trial in Lausanne (2 vaccine injections in 1 limb, 2 vaccine injections in distinct limbs, 2 "vaccine injections" in
Terminated
- Melanoma
- 2 vaccine injections in 1 limb
- +2 more
-
Lausanne, Vaud, SwitzerlandOncology Department, CHUV
May 26, 2020
Stage IV Melanoma, Stage III Melanoma Trial in Australia (IMP321 (eftilagimod alpha), Pembrolizumab)
Completed
- Stage IV Melanoma
- Stage III Melanoma
- IMP321 (eftilagimod alpha)
- Pembrolizumab
-
Brisbane, Queensland, Australia
- +6 more
Dec 17, 2019
Pancreatic Cancer Trial (BNT321 Dose Level 1, BNT321 Dose Level 2, mFOLFIRINOX)
Not yet recruiting
- Pancreatic Cancer
- BNT321 Dose Level 1
- +3 more
- (no location specified)
Sep 29, 2023
Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriatic Arthritis Trial in Worldwide (Bimekizumab,
Completed
- Chronic Plaque Psoriasis
- +2 more
- Bimekizumab
- +2 more
-
Phoenix, Arizona
- +104 more
Jul 15, 2022
Prostate Cancer, 18F- Fluorocholine, PSMA PET Trial (Radiopharmaceutical 18F-JK-PSMA-7, Radiopharmaceutical 18F-Fluorocholine)
Not yet recruiting
- Prostate Cancer
- +5 more
- Radiopharmaceutical 18F-JK-PSMA-7
- Radiopharmaceutical 18F-Fluorocholine
- (no location specified)
Nov 17, 2022
Breast Cancer, Mastectomy; Lymphedema, Same Day Surgery Trial in Washington, Baltimore (Same-day NSM or SSM)
Unknown status
- Breast Cancer
- +4 more
- Same-day NSM or SSM
-
Washington, District of Columbia
- +2 more
Oct 19, 2020
Kidney Failure, Chronic, Hepatitis C Trial in Lucknow (Sofosbuvir, Daclatasvir 60 mg)
Completed
- Kidney Failure, Chronic
- Hepatitis C
- Sofosbuvir
- Daclatasvir 60 mg
-
Lucknow, Uttar Pradesh, IndiaSanjay Gandhi Postgraduate Institute of Medical Sciences
Apr 4, 2021
Chronic Pain Trial in Birmingham, Chapel Hill (Skills TO Manage Pain (STOMP), comparison group)
Active, not recruiting
- Chronic Pain
- Skills TO Manage Pain (STOMP)
- comparison group
-
Birmingham, Alabama
- +1 more
Dec 2, 2022
Encephalitis, Viral Trial (Methylprednisolone, Dexamethasone)
Unknown status
- Encephalitis, Viral
- (no location specified)
Jan 28, 2020
Urinary Bladder, Overactive Trial in Japan (GSK1358820, Placebo)
Hypercholesterolemia, Atherosclerotic Cardiovascular Disease Trial in Tampa, Louisville, Cincinnati (bempedoic acid)
Completed
- Hypercholesterolemia
- Atherosclerotic Cardiovascular Disease
- bempedoic acid
-
Tampa, Florida
- +2 more
Feb 3, 2021
Non-Alcoholic Steatohepatitis Trial in Knoxville (SHP626, Placebo)
Completed
- Non-Alcoholic Steatohepatitis
- SHP626
- Placebo
-
Knoxville, TennesseeNew Orleans Center for Clinical Research
Mar 14, 2019
Acute Gouty Arthritis Trial in United States (Anakinra 100 mg, Triamcinolone Acetonide 40 mg, Placebo to Anakinra 100 mg)
Completed
- Acute Gouty Arthritis
- Anakinra 100 mg
- +3 more
-
Birmingham, Alabama
- +36 more
Jul 1, 2020
Atopic Dermatitis Trial in Worldwide (Tralokinumab, Placebo)
Urinary Bladder, Overactive Trial in Japan (GSK1358820, Placebo, Antibiotic therapy)
HIV, HIV Trial in Worldwide (E/C/F/TAF, E/C/F/TDF, E/C/F/TDF Placebo)
Postoperative Pain, Acute Pain Trial in Salt Lake City (Tapentadol)
Completed
- Postoperative Pain
- Acute Pain
-
Salt Lake City, UtahJean Brown Research
Oct 18, 2019